PDS Biotech Provides Update on National Cancer Institute-Led Phase 2 Clinical Trial of PDS0101-Based Combination
Temporary administrative suspension of recruitment – no safety or efficacy concerns related specifically to the novel PDS0101-based combination studyFLORHAM PARK,...